One approach to eliminating the loss of electricity from overvoltage at the cathode electrode in the technology of microbial fuel cells (MFCs) is the use of microorganisms as biological catalysts for cathodic processes in MFCs. In this paper, the efficiency of MFC with biocathodes based on nitrate-reducing strains of Pseudomonas aeruginosa (3-SW) and (20-SW) isolated from wastewater of the Angarsk Petrochemical Plant (APP) is estimated. Electrical indicators of MFC with biocathodes with P. aeruginosa (20-SW) and P. aeruginosa (3-SW) strains were higher than similar MFC with nitrate cathodes without microorganisms. At the same time, MFC with a biocathode with a P. aeruginosa strain (20-SW) was more effective than a MFC with a biocathode based on P. aeruginosa (3-SW), as in terms of the generated electricity (voltage and current strength of an MFC with P. aeruginosa (20-SW) – 478 ± 12 mV and 1361 ± 133 μA, with (3-SW) – 380 ± 10 mV and 1011 ± 10 μA, respectively), and the degree of elimination of nitrate (from 147.96 ± 9.77 to 0.00 mg/dm3 in the MFC biocathode with P. aeruginosa (20-SW) and from 141.59 ± 11.82 to 54.66 ± 2.39 mg/dm3 in the biocathode with P. aeruginosa (3-SW) during the 96 h experiment). Thus, the conducted studies make it possible to recommend a culture of P. aeruginosa (20-SW), isolated from APP wastewater, to obtain MFC biocathode with its simultaneous use for nitrate wastewater treatment.
Background. Molecular structures combining a phosphorus-containing counterpart and non-polar radicals are employed in design of pro-drugs as structural and functional groups necessary for transportation of drugs through cellular barriers. It is assumed that the carrier itself does not exhibit biological activity. However, the “organic phosphate – alkyl radical” complex may possess its own metabolic and pharmacological properties even in the absence of a drug moiety.The aim. To study the effect of fluorinated alkyl phosphates on the growth of bacterial test cultures in an agar medium and to identify conjugated metabolic markers using UV/visible spectroscopy.Materials and methods. The effect of six organyl phosphates on the growth of five types of bacteria under aerobic conditions was evaluated by the method of wells in an agar medium. For solutions containing cell metabolites of Pseudomonas aeruginosa, the absorption spectra were recorded at 250–280 nm. The principal component analysis (PCA) was used for multivariate comparative analysis of the spectra. Results. The studied organyl phosphates bearing the ethyl and propyl radicals are potential temporary carriers of the drug moiety, since they are capable of penetrating through cellular barriers. However, the fluorinated compounds exhibit bactericidal properties, the degree of which depends on the arrangement of fluorine atoms in the radical. The most active compounds are those exhaustively halogenated at the terminal carbon atom of the ethyl radical (-СН2-СF3), while non-fluorinated organyl phosphate is the least active. UV/visible spectra of P. aeruginosa cultivation products, according to PCA data, contain patterns reflecting the metabolic effects mediated by these structural features of the radicals.Conclusion. In terms of practical application of the studied compounds, the activity of a proantibiotic based on organyl phosphate with a non-fluorinated ethyl(propyl) radical will be determined only by the specificity of the drug moiety. Exactly the same molecule, but exhaustively fluorinated at the terminal carbon atom of the alkyl radical, is likely to be characterized by lower specificity and higher activity under the additive (or synergistic) action of metabolically active groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.